Jefferies Reiterates Buy Rating On CME Group (CME)

Trading volumes at CME Group CME were down sequentially in June compared to May, but according to a report released by Jefferies, "the majority of product segments continue to exhibit favorable year-over-year growth." CME reported ADV of 12.2 million for the month of June compared to 16.8 million in May, but an 8.8% year over year increase. Jefferies has a price target of $380.00 on CME shares. During the current trading session, CME has gained 1.51% to $279.01. CME Group Inc. offers access to all asset classes for futures products from a single electronic trading platform, and on trading floors in Chicago and New York City.